Proteome Sciences Inks Contract with Janssen | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarker services company Proteome Sciences said today that it will analyze samples and perform other services for Janssen Pharmaceutica, a Johnson & Jonson company that specializes in developing drugs for mental health conditions.

Under the contract with Janssen, Proteome Sciences will combine its TMT isobaric mass tag technology, sample preparation, and bioinformatics with mass spectrometry services using Thermo Fisher Scientific's Orbitrap Velos.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.